Flu Shot News

Moderna's newly approved mRNA vaccine could offer a more rapid response to changing influenza strains compared to regular seasonal flu shots. This development r

Moderna's mRNA flu shot, mRNA-1010 (mFLUSIVA), has received FDA approval for adults aged 50 and up, marking the first mRNA flu vaccine to be approved. The appro

The U.S. FDA has approved Moderna's first mRNA flu shot, mFlusiva, for adults aged 50 to 64 with traditional approval and for those 65 and older with accelerate

The U.S. Army's missile stockpiles are diminishing and could take years to replenish, while the FDA is currently evaluating the approval of flu shots utilizing

A new study suggests that vaccine efficacy can be reliably measured each season using existing data and minimizing statistical bias, offering an alternative to